PA8562901A1 - Inhibidores de la fosfatasa - Google Patents

Inhibidores de la fosfatasa

Info

Publication number
PA8562901A1
PA8562901A1 PA20028562901A PA8562901A PA8562901A1 PA 8562901 A1 PA8562901 A1 PA 8562901A1 PA 20028562901 A PA20028562901 A PA 20028562901A PA 8562901 A PA8562901 A PA 8562901A PA 8562901 A1 PA8562901 A1 PA 8562901A1
Authority
PA
Panama
Prior art keywords
phosphatase inhibitors
pyrimido
triazine
useful
relates
Prior art date
Application number
PA20028562901A
Other languages
English (en)
Inventor
Kevin Richard Guertin
Lina Quattrocchio Setti
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8562901A1 publication Critical patent/PA8562901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA I EN DONDE R1 Y R2 SE DEFINEN COMO EN LA REIVINDICACION 1 Y LOS CUALES SON DE UTILIDAD PARA LA ELABORACION DE MEDICAMENTOS.
PA20028562901A 2001-12-27 2002-12-24 Inhibidores de la fosfatasa PA8562901A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US39911002P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
PA8562901A1 true PA8562901A1 (es) 2003-07-28

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028562901A PA8562901A1 (es) 2001-12-27 2002-12-24 Inhibidores de la fosfatasa

Country Status (19)

Country Link
US (1) US6642381B2 (es)
EP (1) EP1467996B1 (es)
JP (1) JP4188839B2 (es)
KR (1) KR100601769B1 (es)
CN (1) CN100402530C (es)
AT (1) ATE311388T1 (es)
AU (1) AU2002367190B2 (es)
BR (1) BR0215395A (es)
CA (1) CA2471265C (es)
DE (1) DE60207759T2 (es)
ES (1) ES2252554T3 (es)
JO (1) JO2242B1 (es)
MX (1) MXPA04006266A (es)
PA (1) PA8562901A1 (es)
PE (1) PE20030896A1 (es)
PL (1) PL371180A1 (es)
TW (1) TW200306313A (es)
UY (1) UY27606A1 (es)
WO (1) WO2003055883A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439834A1 (en) * 2001-10-30 2004-07-28 Applied Research Systems ARS Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
EP1565475B1 (en) 2002-11-18 2009-04-08 F. Hoffmann-La Roche Ag Diazinopyrimidines and their use as protein kinase inhibitors
AU2004210711B2 (en) * 2003-02-12 2010-07-08 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
WO2004071448A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
CN1922151A (zh) * 2004-02-12 2007-02-28 特兰斯泰克制药公司 取代的吡咯衍生物、组合物和使用方法
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
NZ569329A (en) 2006-01-30 2011-09-30 Transtech Pharma Inc Substituted imidazole derivatives and their use as PTPase inhibitors
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
CN105592846A (zh) 2013-03-15 2016-05-18 持田制药株式会社 用于治疗非酒精性脂肪性肝炎的组合物和方法
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194410B1 (en) * 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Also Published As

Publication number Publication date
MXPA04006266A (es) 2004-09-27
AU2002367190A1 (en) 2003-07-15
US6642381B2 (en) 2003-11-04
US20030153756A1 (en) 2003-08-14
DE60207759T2 (de) 2006-08-03
JP4188839B2 (ja) 2008-12-03
AU2002367190B2 (en) 2006-10-05
JO2242B1 (en) 2004-10-07
CN1610683A (zh) 2005-04-27
EP1467996B1 (en) 2005-11-30
UY27606A1 (es) 2003-06-30
ATE311388T1 (de) 2005-12-15
JP2005517677A (ja) 2005-06-16
TW200306313A (en) 2003-11-16
BR0215395A (pt) 2004-12-07
CA2471265A1 (en) 2003-07-10
ES2252554T3 (es) 2006-05-16
KR100601769B1 (ko) 2006-07-19
CA2471265C (en) 2010-02-09
PL371180A1 (en) 2005-06-13
CN100402530C (zh) 2008-07-16
DE60207759D1 (de) 2006-01-05
PE20030896A1 (es) 2003-11-05
EP1467996A1 (en) 2004-10-20
KR20040068981A (ko) 2004-08-02
WO2003055883A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
PA8562901A1 (es) Inhibidores de la fosfatasa
DE69528829D1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
SE0101675D0 (sv) Novel composition
NO20073801L (no) Atineoplastiske kombinasjoner
EA199900373A2 (ru) Фармацевтические композиции
IL172825A0 (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
CY1115124T1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
NO20041493L (no) Kjemiske forbindelser.
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
NO20010718L (no) Ny saltform av pantoprazol
PT1473036E (pt) Solvato de hemitartarato de zolpidem
PE20011085A1 (es) Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos
SE9801494D0 (sv) Novel use
DE60025494D1 (de) Epothilon zusammensetzungen
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
ATE281455T1 (de) Oxindolderivate
PL1628979T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowej fosfatazy tyrozynowej
PL1633754T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowych fosfataz tyrozynowych
PT1144348E (pt) Inibidores de lta, hidrolase
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
MA25965A1 (fr) Production de phosphate bicalcique ou de phosphate monocalcique.
GT199900057A (es) Procedimiento para la preparaciòn de ( s , s ) - bencil - 2,8 - diazabiciclo 4.3.0. nonano.